Exclusivity Information
Duotic holds 1 exclusivity out of which 0 have expired. Its last outstanding exclusivity is set to expire in 2027. Details of Duotic's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Mar 15, 2027 |
About Duotic
Duotic is a drug
owned by DECHRA, LTD.
Duotic uses
Betamethasone Acetate, Terbinafine as the active
ingredients.
Active Ingredient:
Duotic uses
Betamethasone Acetate,
Terbinafine
as the active ingredients.
Check out other Drugs and Companies using
Betamethasone Acetate, Terbinafine ingredient.